10-95038992-T-C

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1

The NM_000770.3(CYP2C8):​c.1196A>G​(p.Lys399Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.103 in 1,613,204 control chromosomes in the GnomAD database, including 9,719 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign,association (no stars).

Frequency

Genomes: 𝑓 0.080 ( 610 hom., cov: 32)
Exomes 𝑓: 0.11 ( 9109 hom. )

Consequence

CYP2C8
NM_000770.3 missense

Scores

1
17

Clinical Significance

Benign; association no assertion criteria provided B:1O:1

Conservation

PhyloP100: 0.323

Publications

224 publications found
Variant links:
Genes affected
CYP2C8 (HGNC:2622): (cytochrome P450 family 2 subfamily C member 8) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize many xenobiotics, including the anticonvulsive drug mephenytoin, benzo(a)pyrene, 7-ethyoxycoumarin, and the anti-cancer drug taxol. This gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. Several transcript variants encoding a few different isoforms have been found for this gene. [provided by RefSeq, Nov 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0021723509).
BP6
Variant 10-95038992-T-C is Benign according to our data. Variant chr10-95038992-T-C is described in ClinVar as [Benign, association]. Clinvar id is 375654.Status of the report is no_assertion_criteria_provided, 0 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.112 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CYP2C8NM_000770.3 linkc.1196A>G p.Lys399Arg missense_variant Exon 8 of 9 ENST00000371270.6 NP_000761.3 P10632-1
CYP2C8NM_001198853.1 linkc.986A>G p.Lys329Arg missense_variant Exon 8 of 9 NP_001185782.1 P10632B7Z1F5
CYP2C8NM_001198855.1 linkc.986A>G p.Lys329Arg missense_variant Exon 9 of 10 NP_001185784.1 P10632B7Z1F5
CYP2C8NM_001198854.1 linkc.890A>G p.Lys297Arg missense_variant Exon 7 of 8 NP_001185783.1 P10632-2B7Z1F5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CYP2C8ENST00000371270.6 linkc.1196A>G p.Lys399Arg missense_variant Exon 8 of 9 1 NM_000770.3 ENSP00000360317.3 P10632-1

Frequencies

GnomAD3 genomes
AF:
0.0798
AC:
12149
AN:
152168
Hom.:
610
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0212
Gnomad AMI
AF:
0.152
Gnomad AMR
AF:
0.0924
Gnomad ASJ
AF:
0.0913
Gnomad EAS
AF:
0.000576
Gnomad SAS
AF:
0.0377
Gnomad FIN
AF:
0.113
Gnomad MID
AF:
0.152
Gnomad NFE
AF:
0.114
Gnomad OTH
AF:
0.105
GnomAD2 exomes
AF:
0.0834
AC:
20976
AN:
251410
AF XY:
0.0850
show subpopulations
Gnomad AFR exome
AF:
0.0202
Gnomad AMR exome
AF:
0.0675
Gnomad ASJ exome
AF:
0.0990
Gnomad EAS exome
AF:
0.000381
Gnomad FIN exome
AF:
0.110
Gnomad NFE exome
AF:
0.115
Gnomad OTH exome
AF:
0.101
GnomAD4 exome
AF:
0.106
AC:
154417
AN:
1460918
Hom.:
9109
Cov.:
30
AF XY:
0.104
AC XY:
75770
AN XY:
726856
show subpopulations
African (AFR)
AF:
0.0185
AC:
620
AN:
33472
American (AMR)
AF:
0.0717
AC:
3207
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0956
AC:
2498
AN:
26126
East Asian (EAS)
AF:
0.000151
AC:
6
AN:
39692
South Asian (SAS)
AF:
0.0432
AC:
3724
AN:
86244
European-Finnish (FIN)
AF:
0.110
AC:
5861
AN:
53412
Middle Eastern (MID)
AF:
0.121
AC:
697
AN:
5768
European-Non Finnish (NFE)
AF:
0.119
AC:
131989
AN:
1111108
Other (OTH)
AF:
0.0963
AC:
5815
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
6633
13266
19899
26532
33165
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4742
9484
14226
18968
23710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0798
AC:
12145
AN:
152286
Hom.:
610
Cov.:
32
AF XY:
0.0791
AC XY:
5892
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.0211
AC:
878
AN:
41572
American (AMR)
AF:
0.0923
AC:
1411
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.0913
AC:
317
AN:
3472
East Asian (EAS)
AF:
0.000385
AC:
2
AN:
5192
South Asian (SAS)
AF:
0.0378
AC:
182
AN:
4820
European-Finnish (FIN)
AF:
0.113
AC:
1199
AN:
10596
Middle Eastern (MID)
AF:
0.156
AC:
46
AN:
294
European-Non Finnish (NFE)
AF:
0.114
AC:
7751
AN:
68018
Other (OTH)
AF:
0.104
AC:
220
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
584
1168
1751
2335
2919
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
138
276
414
552
690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.103
Hom.:
4436
Bravo
AF:
0.0778
TwinsUK
AF:
0.123
AC:
456
ALSPAC
AF:
0.119
AC:
459
ESP6500AA
AF:
0.0245
AC:
108
ESP6500EA
AF:
0.117
AC:
1003
ExAC
AF:
0.0826
AC:
10028
Asia WGS
AF:
0.0150
AC:
55
AN:
3478
EpiCase
AF:
0.120
EpiControl
AF:
0.119

ClinVar

Significance: Benign; association
Submissions summary: Benign:1Other:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

CYP2C8-related disorder Benign:1
Oct 29, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Pulmonary disease, chronic obstructive, susceptibility to Other:1
Jul 05, 2022
HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas
Significance:association
Review Status:no assertion criteria provided
Collection Method:research

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.085
BayesDel_addAF
Benign
-0.60
T
BayesDel_noAF
Benign
-0.54
CADD
Benign
6.4
DANN
Benign
0.95
DEOGEN2
Benign
0.25
.;.;.;T
Eigen
Benign
-0.95
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.045
N
LIST_S2
Benign
0.73
.;T;T;T
MetaRNN
Benign
0.0022
T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.6
.;.;.;M
PhyloP100
0.32
PrimateAI
Benign
0.23
T
PROVEAN
Benign
-2.3
.;N;.;N
REVEL
Benign
0.054
Sift
Benign
0.046
.;D;.;T
Sift4G
Benign
0.15
T;T;T;T
Polyphen
0.021
.;.;.;B
Vest4
0.095
MPC
0.021
ClinPred
0.014
T
GERP RS
-1.4
Varity_R
0.23
gMVP
0.041
Mutation Taster
=83/17
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10509681; hg19: chr10-96798749; COSMIC: COSV64875925; COSMIC: COSV64875925; API